ENTRY       D11125                      Drug
NAME        Modotuximab (USAN/INN)
FORMULA     C6500H10022N1722O2040S48
EXACT_MASS  146378.0011
MOL_WEIGHT  146468.5581
SEQUENCE    (Heavy chain)
            QVQLQQPGAE LVEPGGSVKL SCKASGYTFT SHWMHWVKQR PGQGLEWIGE INPSSGRNNY
            NEKFKSKATL TVDKSSSTAY MQFSSLTSED SAVYYCVRYY GYDEAMDYWG QGTSVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKRVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSREEM
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPG
            (Light chain)
            DIVMTQAAFS NPVTLGTSAS ISCRSSKSLL HSNGITYLYW YLQKPGQSPQ LLIYQMSNLA
            SGVPDRFSSS GSGTDFTLRI SRVEAEDVGV YYCAQNLELP YTFGGGTKLE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (Disulfide bridge: H22-H96, H146-H202, H222-L219, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'96, H'146-H'202, H'222-L'219, H'263-H'323, H'369-H'427, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody
COMMENT     Treatment of cancer
TARGET      EGFR [HSA:1956] [KO:K04361]
  PATHWAY   hsa04014(1956)  Ras signaling pathway
            hsa04151(1956)  PI3K-Akt signaling pathway
            hsa05200(1956)  Pathways in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               EGFR family
                EGFR
                 D11125  Modotuximab (USAN/INN)
DBLINKS     CAS: 1310460-86-6
            PubChem: 376219049
///
